Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-DEP for Refractory EBV-HLH
NCT02631109Phase 3Unknown
- Sponsor
- Beijing Friendship Hospital
- Start
- Dec 2015
- Primary completion
- Nov 2017
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pegaspargase in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH), sponsored by Beijing Friendship Hospital. Status: unknown.
02
Drugs
pegaspargase
03
Conditions
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH)
Beyond the preview
Go deeper on NCT02631109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02631109.